BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27613110)

  • 1. Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from a cohort study.
    van der Heyden JC; Birnie E; Mul D; Bovenberg S; Veeze HJ; Aanstoot HJ
    BMC Endocr Disord; 2016 Sep; 16(1):49. PubMed ID: 27613110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Skin Autofluorescence and Its Association with Glycated Hemoglobin, Cardiovascular Risk Markers, and Concomitant Chronic Diseases in Children with Type 1 Diabetes.
    Jankowska M; Szadkowska A; Pietrzak I; Chrzanowski J; Sołek J; Fendler W; Mianowska B
    Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus.
    Banser A; Naafs JC; Hoorweg-Nijman JJ; van de Garde EM; van der Vorst MM
    Pediatr Diabetes; 2016 Sep; 17(6):426-32. PubMed ID: 26332801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle and clinical determinants of skin autofluorescence in a population-based cohort study.
    van Waateringe RP; Slagter SN; van der Klauw MM; van Vliet-Ostaptchouk JV; Graaff R; Paterson AD; Lutgers HL; Wolffenbuttel BH
    Eur J Clin Invest; 2016 May; 46(5):481-90. PubMed ID: 27002914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of skin autofluorescence as a surrogate of advanced glycation end products accumulation in children and adolescents with normal haemoglobin A1c values.
    Jankowska M; Bobeff K; Baranowska-Jaźwiecka A; Mianowska M; Lubnauer A; Michalak A; Młynarski W; Szadkowska A; Mianowska B
    Pediatr Endocrinol Diabetes Metab; 2020; 26(1):1-9. PubMed ID: 32418416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autofluorescence of Skin Advanced Glycation End Products: Marker of Metabolic Memory in Elderly Population.
    Rajaobelina K; Cougnard-Gregoire A; Delcourt C; Gin H; Barberger-Gateau P; Rigalleau V
    J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):841-6. PubMed ID: 25589479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of skin autofluorescence of AGEs over 4 years in patients with type 1 diabetes.
    Rajaobelina K; Helmer C; Vélayoudom-Céphise FL; Nov S; Farges B; Pupier E; Blanco L; Hugo M; Gin H; Rigalleau V
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28719154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Bright Side of Skin Autofluorescence Determination in Children and Adolescents with Newly Diagnosed Type 1 Diabetes Mellitus: A Potential Predictor of Remission?
    Podolakova K; Barak L; Jancova E; Stanik J; Sebekova K; Podracka L
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products as predictors of renal function in youth with type 1 diabetes.
    Forbes JM; Le Bagge S; Righi S; Fotheringham AK; Gallo LA; McCarthy DA; Leung S; Baskerville T; Nisbett J; Morton A; Teasdale S; D'Silva N; Barrett H; Jones T; Couper J; Donaghue K; Isbel N; Johnson DW; Donnellan L; Deo P; Akison LK; Moritz KM; O'Moore-Sullivan T
    Sci Rep; 2021 May; 11(1):9422. PubMed ID: 33941808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin autofluorescence and glycemic variability.
    Noordzij MJ; Lefrandt JD; Graaff R; Smit AJ
    Diabetes Technol Ther; 2010 Jul; 12(7):581-5. PubMed ID: 20597834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.
    Blanc-Bisson C; Velayoudom-Cephise FL; Cougnard-Gregoire A; Helmer C; Rajaobelina K; Delcourt C; Alexandre L; Blanco L; Mohammedi K; Monlun M; Rigalleau V
    Cardiovasc Diabetol; 2018 Jun; 17(1):82. PubMed ID: 29884175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin autofluorescence, renal insufficiency and retinopathy in patients with type 2 diabetes.
    Bentata R; Cougnard-Grégoire A; Delyfer MN; Delcourt C; Blanco L; Pupier E; Rougier MB; Rajaobelina K; Hugo M; Korobelnik JF; Rigalleau V
    J Diabetes Complications; 2017 Mar; 31(3):619-623. PubMed ID: 28063765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products, measured as skin autofluorescence, during normal pregnancy and pregnancy complicated by diabetes mellitus.
    de Ranitz-Greven WL; Kaasenbrood L; Poucki WK; Hamerling J; Bos DC; Visser GH; Biesma DH; Beulens JW; de Valk HW
    Diabetes Technol Ther; 2012 Dec; 14(12):1134-9. PubMed ID: 23113747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus.
    Genevieve M; Vivot A; Gonzalez C; Raffaitin C; Barberger-Gateau P; Gin H; Rigalleau V
    Diabetes Metab; 2013 Sep; 39(4):349-54. PubMed ID: 23643347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin autofluorescence and the complexity of complications in patients with type 2 diabetes mellitus: a cross-sectional study.
    Wang X; Zhao X; Lian T; Wei J; Yue W; Zhang S; Chen Q
    BMC Endocr Disord; 2021 Apr; 21(1):58. PubMed ID: 33794864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher skin autofluorescence in young people with Type 1 diabetes and microvascular complications.
    Cho YH; Craig ME; Januszewski AS; Benitez-Aguirre P; Hing S; Jenkins AJ; Donaghue KC
    Diabet Med; 2017 Apr; 34(4):543-550. PubMed ID: 27770590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. For diabetic type 1 patients, the skin autofluorescence predicts ulcers and amputations.
    Rojubally S; Simoneau A; Monlun M; Foussard N; Blanco L; Domenge F; Mohammedi K; Ducasse E; Caradu C; Rigalleau V
    J Diabetes Complications; 2021 Mar; 35(3):107808. PubMed ID: 33386214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of advanced glycation end products in the skin is accelerated in relation to insulin resistance in people with Type 1 diabetes mellitus.
    Uruska A; Gandecka A; Araszkiewicz A; Zozulinska-Ziolkiewicz D
    Diabet Med; 2019 May; 36(5):620-625. PubMed ID: 30706538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin autofluorescence: Correlation with measures of diabetic sensorimotor neuropathy.
    Stirban AO; Bondor CI; Florea B; Veresiu IA; Gavan NA
    J Diabetes Complications; 2018 Sep; 32(9):851-856. PubMed ID: 30025785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin autofluorescence in children with and without obesity.
    Lentferink YE; van Teeseling L; Knibbe CAJ; van der Vorst MMJ
    J Pediatr Endocrinol Metab; 2019 Jan; 32(1):41-47. PubMed ID: 30530882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.